Current and future therapies for herpes simplex virus infections: mechanism of action and drug resistance.

@article{James2014CurrentAF,
  title={Current and future therapies for herpes simplex virus infections: mechanism of action and drug resistance.},
  author={Scott H. James and Mark N Prichard},
  journal={Current opinion in virology},
  year={2014},
  volume={8},
  pages={
          54-61
        }
}
Forty years after the discovery of acyclovir (ACV), it remains the mainstay of therapy for herpes simplex virus (HSV) infections. Since then, other antiviral agents have also been added to the armamentarium for these infections but ACV remains the therapy of choice. As the efficacy of ACV is reassessed, however, it is apparent that a therapy with increased efficacy, reduced potential for resistance, and improved pharmacokinetics would improve clinical outcome, particularly in high risk patients… CONTINUE READING

Citations

Publications citing this paper.
SHOWING 1-10 OF 33 CITATIONS

Bacteriocin: the avenues of innovation towards applied microbiology

VIEW 6 EXCERPTS
CITES BACKGROUND
HIGHLY INFLUENCED